CAMBRIDGE, England, September 16, 2014 /PRNewswire/ --
Sphere Fluidics Limited has developed unique technology for single cell analysis and characterization and provides proprietary products and novel services for this rapidly-growing market. The Company has raised over $6 million to date. "We are starting to develop a brand new single cell analysis instrument called Cyto-Mine™ (see image below). This will be revolutionary for the Biopharmaceutical Discovery and Development market. After an exacting selection process, we have selected Cambridge Consultants Limited as our partner in the product engineering. They are a world-class technology consultancy business with expertise in microfluidics, optoelectronics and picodroplet areas - critical for success," said Dr. Frank F. Craig (CEO of Sphere Fluidics).
"This new instrument can accelerate and enable the discovery of diverse antibodies from primary B-cells or hybridomas. It can perform millions of novel single cell or cell-cell co-incubation assays per day and dramatically improve biopharmaceutical discovery. Its novel features enable it to identify and retrieve single cells from vast populations of transformed cells to speed biopharmaceutical development. It also offers up to 100-fold improvements in monoclonality and improved recovery of single cells compared to conventional techniques," said Dr. Marian Rehak (R&D Director, Sphere Fluidics Limited). "The market potential is also visible in synthetic biology, antibiotic-resistance screening and single cell diagnostics so this will be a huge, global seller," added Dr. Frank Craig.
"We are pleased to be working with Sphere Fluidics," said John Pritchard, head of diagnostics at Cambridge Consultants. "Our track record of engineering excellence makes Cambridge Consultants the development partner of choice for clients ranging from small, ambitious start-ups right the way through to multinational blue-chip organisations."
"Our unique mixture of multidisciplinary skills underpinned by deep core science expertise - coupled with our 50-year history of helping clients bring innovative products to market fast - means we can give companies vital competitive edge when it comes to clinical diagnostics and Life Science instrumentation."
Sphere Fluidics Limited. Contact Dr Frank F. Craig on:
Cambridge Consultants. Contact Debbie Mayhew on:
SOURCE Sphere Fluidics Limited